Telotristat Ethyl: Carcinoid Syndrome Diarrhea

In an effort to promote higher quality patient care the National Community Oncology Dispensing Association, Inc (NCODA), created the NCODA Positive Quality Intervention (PQI) as a peer reviewed clinical guidance document for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet simple-to-use resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the Xermelo (telotristat ethyl) PQI and explores how the medically integrated teams at Boston Medical Center and Oklahoma Cancer Specialists and Research Institute incorporate PQI’s as part of their daily workflow. It will discuss how utilizing the telotristat ethyl PQI elevates patient care.